Síndrome do ovário policístico (Portuguese Wikipedia)

Analysis of information sources in references of the Wikipedia article "Síndrome do ovário policístico" in Portuguese language version.

refsWebsite
Global rank Portuguese rank
4th place
8th place
2nd place
4th place
5th place
5th place
274th place
339th place
1,389th place
585th place
1st place
1st place
low place
low place
low place
low place
719th place
598th place
low place
low place
low place
8,362nd place
2,747th place
1,815th place
7,131st place
2,469th place
216th place
151st place
610th place
360th place
3,011th place
2,540th place
low place
low place
1,610th place
991st place
low place
low place
low place
4,149th place
low place
low place
low place
low place
low place
low place
low place
low place
857th place
314th place
4,730th place
2,409th place
low place
low place
low place
7,571st place
low place
low place
low place
low place
6,828th place
3,114th place
1,195th place
1,007th place
low place
low place
low place
low place
low place
low place
low place
low place
low place
2,516th place
149th place
155th place
6,250th place
1,859th place
low place
low place
low place
low place
485th place
414th place
1,226th place
1,055th place
low place
low place
3,258th place
5,177th place
low place
low place
24th place
18th place
low place
low place
2,374th place
2,630th place
low place
424th place
1,989th place
1,732nd place
low place
low place
87th place
24th place
low place
low place
6,313th place
5,481st place
low place
low place
low place
low place
8th place
13th place
139th place
327th place

abc.net.au

abcdasaude.com.br

about.com

pcos.about.com

womeninbusiness.about.com

anvisa.gov.br

portal.anvisa.gov.br

archive.is

bbc.co.uk

biomedcentral.com

blogs.com

laparoscopy.blogs.com

bmj.com

carbsandcals.com

cwhn.ca

doi.org

dx.doi.org

dovepress.com

dusunenadamdergisi.org

elsevier.com

linkinghub.elsevier.com

endocrine-abstracts.org

endocrine.org

press.endocrine.org

environmentalhealthnews.org

epistemonikos.org

examiner.com

febrasgo.org.br

fertstert.org

glowm.com

hindawi.com

informahealthcare.com

ircmj.com

  • Female Gender Scheme is Disturbed by Polycystic Ovary Syndrome: A Qualitative Study From Iran. Fatemeh Nasiri Amiri; Fahimeh Ramezani Tehrani; Masoumeh Simbar; Reza Ali Mohammadpour Thamtan; And Niloofar Shiva. Iranian Red Crescent Medical Journal. 16(2): E12423 , DOI: 10.5812/ircmj.12423. Article Type: Research Article; Received: May 22, 2013; Revised: Jul 3, 2013; Accepted: Jul 15, 2013; Epub: Feb 7, 2014; Collection: Feb 2014 (http://ircmj.com/?page=article&article_id=12423)

jarrettfertility.com

labtestsonline.org.br

  • Lab Tests On-line. Ovário Policístico [2]). Este artigo foi modificado pela última vez em 04 de fevereiro de 2013.

laparoscopiaginecologica.net.br

mayoclinic.org

medicalnewstoday.com

  • Medical News Today: What is Polycystic Ovary Syndrome (PCOS)? [1]

medscape.com

emedicine.medscape.com

mgfamiliar.net

moreirajr.com.br

  • Hiperandrogenismo na síndrome dos ovários policísticos (SOP). Revista Brasileira de Medicina. Hans Wolfgang Halbe; Ângela Maggio da Fonseca; Laudelino de Oliveira Ramos; Carlos Roberto Izzo; Sylvia A. Y. Hayashida. Trabalho realizado no LIM 058, FMUSP. Recebido para publicação em 03/2004. Aceito em 04/2004 (http://www.moreirajr.com.br/revistas.asp?fase=r003&id_materia=2796).

msdonline.com.br

mmspf.msdonline.com.br

nejm.org

nhs.uk

nice.org.uk

guidance.nice.org.uk

  • National Institute for Health and Clinical Excellence. 11 Clinical guideline 11 : Fertility: assessment and treatment for people with fertility problems . London, 2004. (http://guidance.nice.org.uk/CG).

nih.gov

ncbi.nlm.nih.gov

  • Goldenberg N, Glueck C (2008). "Medical therapy in women with polycystic ovary syndrome before and during pregnancy and lactation". Minerva Ginecol 60 (1): 63–75.PMID 18277353
  • Boomsma CM, Fauser BC, Macklon NS (2008). "Pregnancy complications in women with polycystic ovary syndrome". Semin. Reprod. Med. 26 (1): 72–84.doi:10.1055/s-2007-992927. PMID 18181085.
  • Azziz R, Woods KS, Reyna R, Key TJ, Knochenhauer ES, Yildiz BO (June 2004). "The Prevalence and Features of the Polycystic Ovary Syndrome in an Unselected Population".Journal of Clinical Endocrinology & Metabolism 89 (6): 2745–9. doi:10.1210/jc.2003-032046. PMID 15181052.
  • Palomba, Stefano; Santagni, Susanna; Falbo, Angela; La Sala, Giovanni Battista (julho de 2015). «Complications and challenges associated with polycystic ovary syndrome: current perspectives». International Journal of Women's Health (em inglês). 745 páginas. ISSN 1179-1411. PMC PMC4527566Acessível livremente Verifique |pmc= (ajuda). PMID 26261426. doi:10.2147/IJWH.S70314. Consultado em 7 de setembro de 2022 
  • Polycystic ovary syndrome. Polycystic ovaries; Polycystic ovary disease; Stein-Leventhal syndrome; Polyfollicular ovarian disease. Last reviewed: February 26, 2012 (http://www.ncbi.nlm.nih.gov/pubmedhealth/PMH0001408).
  • Legro RS; Strauss JF (September 2002). "Molecular progress in infertility: polycystic ovary syndrome". Fertility and Sterility 78 (3): 569–576.doi:10.1016/S0015-0282(02)03275-2. PMID 12215335.
  • Carvalho, Laura M. L.; Ferreira, Cláudia N.; de Oliveira, Daisy K. D.; Rodrigues, Kathryna F.; Duarte, Rita C. F.; Teixeira, Márcia F. A.; Xavier, Luana B.; Candido, Ana Lúcia; Reis, Fernando M. (dezembro de 2017). «Haptoglobin levels, but not Hp1-Hp2 polymorphism, are associated with polycystic ovary syndrome». Journal of Assisted Reproduction and Genetics (em inglês) (12): 1691–1698. ISSN 1058-0468. PMC PMC5714822Acessível livremente Verifique |pmc= (ajuda). PMID 28900795. doi:10.1007/s10815-017-1030-3. Consultado em 8 de setembro de 2022 
  • http://www.ncbi.nlm.nih.gov/pubmed/21528473.
  • Diamanti-Kandarakis E; Kandarakis H, Legro RS (August 2006). "The role of genes and environment in the etiology of PCOS". Endocrine 30(1): 19–26. doi:10.1385/ENDO:30:1:19. PMID 17185788.
  • Crosignani PG, Nicolosi AE (2001). "Polycystic ovarian disease: heritability and heterogeneity". Hum. Reprod. Update 7 (1): 3–7. doi:10.1093/humupd/7.1.3.PMID 11212071.
  • Strauss JF 3rd (November 2003). "Some new thoughts on the pathophysiology and genetics of polycystic ovary syndrome". Annals of the New York Academy of Sciences 997: 42–48. doi:10.1196/annals.1290.005.PMID 14644808.
  • Overexpression of a DENND1A isoform produces a polycystic ovary syndrome theca phenotype. McAllister JM, Modi B, Miller BA, Biegler J, Bruggeman R, Legro RS, Strauss JF 3rd. Proceedings of the National Academy of Sciences. 2014 Apr 15;111(15):E1519-27. doi: 10.1073/pnas.1400574111. Epub 2014 Mar 31. (http://www.ncbi.nlm.nih.gov/pubmed/24706793).
  • Genetics of polycystic ovary syndrome. Welt CK, Duran JM. Seminars in Reproductive Medicine. 2014 May;32(3):177-82. doi: 10.1055/s-0034-1371089. Epub 2014 Apr 8. (http://www.ncbi.nlm.nih.gov/pubmed/24715512).
  • Industrial endocrine disruptors and polycystic ovary syndrome. Palioura E, Diamanti-Kandarakis E. J Endocrinol Invest. 2013 Dec;36(11):1105-11 (http://www.ncbi.nlm.nih.gov/pubmed/24445124)
  • Bisphenol A (BPA) and its potential role in the pathogenesis of the polycystic ovary syndrome (PCOS). Rutkowska A, Rachoń D. Gynecol Endocrinol. 2014 Apr;30(4):260-5. doi: 10.3109/09513590.2013.871517. Epub 2014 Jan 7. PMID 24397396 [PubMed - in process] (http://www.ncbi.nlm.nih.gov/pubmed/24397396).
  • Endocrine Disruptors and Polycystic Ovary Syndrome (PCOS): Elevated Serum Levels of Bisphenol A in Women with PCOS. Eleni Kandaraki, Antonis Chatzigeorgiou, Sarantis Livadas, Eleni Palioura, Frangiscos Economou, Michael Koutsilieris, Sotiria Palimeri, Dimitrios Panidis, and Evanthia Diamanti-Kandarakis. ISSN Print 0021-972X ISSN Online 1945-7197. Printed in U.S.A. The Endocrine Society. doi: 10.1210/jc.2010-1658. Received July 19, 2010. Accepted November 23, 2010. First Published Online December 30, 2010 (http://www.ncbi.nlm.nih.gov/pubmed/21193545)
  • Le Corre L, Besnard P, Chagnon MC. BPA, an Energy Balance Disruptor. Crit Rev Food Sci Nutr. 2013 Sep 20 (http://www.ncbi.nlm.nih.gov/pubmed/24915348).
  • Impact of early-life bisphenol A exposure on behavior and executive function in children. Braun JM, Kalkbrenner AE, Calafat AM, Yolton K, Ye X, Dietrich KN, Lanphear BP. Pediatrics. 2011 Nov;128(5):873-82. doi: 10.1542/peds.2011-1335. Epub 2011 Oct 24 (http://www.ncbi.nlm.nih.gov/pubmed/22025598).
  • Sex Specific Estrogen Receptor beta (ERβ) mRNA Expression in the Rat Hypothalamus and Amygdala is Altered by Neonatal Bisphenol A (BPA) Exposure. Jinyan Cao, Linwood Joyner, Jillian A. Mickens, Stephanie M Leyrer and Heather B Patisaul. Reproduction. 2014; 147(4): 537–554. Published online Mar 4, 2014. doi:  10.1530/REP-13-0501 (http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3947720/).
  • Polycystic ovary syndrome: do endocrine-disrupting chemicals play a role? Barrett ES, Sobolewski M. Semin Reprod Med. 2014 May;32(3):166-76. doi: 10.1055/s-0034-1371088. Epub 2014 Apr 8 (http://www.ncbi.nlm.nih.gov/pubmed/24715511).
  • Bisphenol A and human health: a review of the literature. Rochester JR. Reprod Toxicol. 2013 Dec;42:132-55. doi: 10.1016/j.reprotox.2013.08.008. Epub 2013 Aug 30 (http://www.ncbi.nlm.nih.gov/pubmed/23994667).
  • Bisphenol A in polycystic ovary syndrome and its association with liver-spleen axis. Tarantino G, Valentino R, Di Somma C, D'Esposito V, Passaretti F, Pizza G, Brancato V, Orio F, Formisano P, Colao A, Savastano S. Clin Endocrinol (Oxf). 2013 Mar;78(3):447-53. doi: 10.1111/j.1365-2265.2012.04500.x. (http://www.ncbi.nlm.nih.gov/pubmed/22805002).
  • Phenotypes and enviromental factors: their influence in PCOS. Diamanti-Kandarakis E, Christakou C, Marinakis E. Curr Pharm Des. 2012;18(3):270-82 (http://www.ncbi.nlm.nih.gov/pubmed/22229564).
  • Endocrine-Disrupting Chemicals: Some Actions of POPs on Female Reproduction. Gregoraszczuk EL, Ptak A. Int J Endocrinol. 2013;2013:828532. doi: 10.1155/2013/828532. Epub 2013 May 23. (http://www.ncbi.nlm.nih.gov/pubmed/23762054).
  • Polycystic Ovaries and Polycystic Ovary Syndrome in Epilepsy: Evidence for Neurogonadal Disease. Cynthia L Harden, MD. Epilepsy Curr. Jul 2005; 5(4): 142–146. doi:  10.1111/j.1535-7511.2005.00039.x. (http://www.ncbi.nlm.nih.gov/pmc/articles/PMC1198730/).
  • The relationship between polycystic ovary syndrome and antiepileptic drugs: a review of the evidence. Rasgon N. J Clin Psychopharmacol. 2004 Jun;24(3):322-34 (http://www.ncbi.nlm.nih.gov/pubmed/15118487).
  • Urinary levels of insecticide metabolites and DNA damage in human sperm. John D.Meeker; Narendra P.Singh, Louise Ryan, Susan M.Duty, Dana B.Barr, Robert F.Herrick, Deborah H.Bennett and Russ Hauser. Human Reproduction Vol.19, No.11 pp. 2573–2580, 2004. Advance Access publication August 27, 2004. doi:10.1093/humrep/deh444 (http://www.ncbi.nlm.nih.gov/pubmed/15333606).
  • Cycle characteristics after discontinuation of oral contraceptives. Gnoth C, Frank-Herrmann P, Schmoll A, Godehardt E, Freundl G. Gynecol Endocrinol 2002:16(4): 307-17. PMID 12396560 [PubMed - indexed for MEDLINE] [5]
  • http://www.ncbi.nlm.nih.gov/pubmedhealth/PMH0001408/
  • Huang A, Brennan K, Azziz R (April 2010). "Prevalence of hyperandrogenemia in the polycystic ovary syndrome diagnosed by the National Institutes of Health 1990 criteria". Fertil. Steril. 93 (6): 1938–41.doi:10.1016/j.fertnstert.2008.12.138. PMC 2859983.PMID 19249030.
  • Nafiye Y, Sevtap K, Muammer D, Emre O, Senol K, Leyla M (April 2010). "The effect of serum and intrafollicular insulin resistance parameters and homocysteine levels of nonobese, nonhyperandrogenemic polycystic ovary syndrome patients on in vitro fertilization outcome". Fertil. Steril. 93 (6): 1864–9.doi:10.1016/j.fertnstert.2008.12.024. PMID 19171332.
  • Fattah NS, Darwish YW. Androgenetic alopecia and insulin resistance - Are they truly associated? Int J Dermatol. 2011:50(4);417-422 (http://www.ncbi.nlm.nih.gov/pubmed/21413951)
  • Psoriatic patients have an increased risk of polycystic ovary syndrome: results of a cross-sectional analysis. Moro F1, De Simone C, Morciano A, Tropea A, Sagnella F, Palla C, Scarinci E, Teti A, Caldarola G, D'Agostino M, Mancuso S, Lanzone A, Apa R. (http://www.ncbi.nlm.nih.gov/pubmed/23158933)
  • Goldenberg N, Glueck C (2008). "Medical therapy in women with polycystic ovary syndrome before and during pregnancy and lactation". Minerva Ginecol 60 (1): 63–75.PMID 18277353
  • Boomsma CM, Fauser BC, Macklon NS (2008). "Pregnancy complications in women with polycystic ovary syndrome". Semin. Reprod. Med. 26 (1): 72–84.doi:10.1055/s-2007-992927. PMID 18181085.
  • Thozhukat Sathyapalan; Stephen L. Atkin (2010)."Mediators of Inflammation in Polycystic Ovary Syndrome in Relation to Adiposity". Mediators of Inflammation(Hindawi) 2010: 758656. doi:10.1155/2010/758656.PMC 2852606. PMID 20396393 (http://www.hindawi.com/journals/mi/2010/758656/).
  • Fukuoka M, Yasuda K, Fujiwara H, Kanzaki H, Mori T (1992). "Interactions between interferon gamma, tumour necrosis factor alpha, and interleukin-1 in modulating progesterone and oestradiol production by human luteinized granulosa cells in culture". Hum Reprod 7 (10): 1361–4. PMID 1291559 (https://www.ncbi.nlm.nih.gov/pubmed/1291559).
  • González F, Rote N, Minium J, Kirwan J (2006). "Reactive oxygen species-induced oxidative stress in the development of insulin resistance and hyperandrogenism in polycystic ovary syndrome". J Clin Endocrinol Metab 91 (1): 336–40.doi:10.1210/jc.2005-1696. PMID 16249279 (http://press.endocrine.org/doi/abs/10.1210/jc.2005-1696).
  • Murri, Mora; Luque-Ramírez, Manual et al. (2013). "Circulating markers of oxidative stress and polycystic ovary syndrome (PCOS): a systematic review and meta-analysis". Hum. Reprod. Update 19 (3): 268-288. doi:10.1093/humupd/dms059. PMID 23303572 (http://humupd.oxfordjournals.org/content/19/3/268)
  • Polycystic ovaries and the polycystic ovary syndrome phenotype in women with active acromegaly. Kaltsas GA, Androulakis II, Tziveriotis K, Papadogias D, Tsikini A, Makras P, Dimitriou K, Stathopoulou A, Piaditis G. Clinical endocrinology (Oxford).  2007 Dec;67(6):917-22. Epub 2007 Jul 25. (http://www.ncbi.nlm.nih.gov/pubmed/17651451).
  • Women with polycystic ovary syndrome are often depressed or anxious--a case control study. Månsson M1, Holte J, Landin-Wilhelmsen K, Dahlgren E, Johansson A, Landén M. Psychoneuroendocrinology. 2008 Sep;33(8):1132-8. doi: 10.1016/j.psyneuen.2008.06.003. Epub 2008 Jul 30. (http://www.ncbi.nlm.nih.gov/pubmed/18672334).
  • Testosterone and mood dysfunction in women with polycystic ovarian syndrome compared to subfertile controls. Barry JA, Hardiman PJ, Saxby BK, Kuczmierczyk A. J Psychosom Obstet Gynaecol. 2011 Jun;32(2):104-11. doi: 10.3109/0167482X.2011.568129. Epub 2011 Apr 7. (http://www.ncbi.nlm.nih.gov/pubmed/21473679).
  • Impact of Obstructive Sleep Apnea on Insulin Resistance and Glucose Tolerance in Women with Polycystic Ovary Syndrome. Esra Tasali, Eve Van Cauter, Leslie Hoffman, and David A. Ehrmann. Published online Jul 22, 2008. doi: 10.1210/jc.2008-0925 (http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2579653/)
  • Distinctive features of female-to-male transsexualism and prevalence of gender identity disorder in Japan. Baba T, Endo T, Ikeda K, Shimizu A, Honnma H, Ikeda H, Masumori N, Ohmura T, Kiya T, Fujimoto T, Koizumi M, Saito T. J Sex Med. 2011 Jun;8(6):1686-93. doi: 10.1111/j.1743-6109.2011.02252.x. Epub 2011 Apr 7.PMID 21477021 [PubMed - indexed for MEDLINE]. US National Library of Medicine National Institutes of Health (http://www.ncbi.nlm.nih.gov/pubmed/21477021).
  • Psychological gender of patients with polycystic ovary syndrome. Kowalczyk R, Skrzypulec V, Lew-Starowicz Z, Nowosielski K, Grabski B, Merk W. Acta Obstet Gynecol Scand. 2012 Mar 24. doi: 10.1111/j.1600-0412.2012.01408.x (http://www.ncbi.nlm.nih.gov/pubmed/22443151)
  • Correlates of increased lean muscle mass in women with polycystic ovary syndrome. Carmina E, Guastella E, Longo RA, Rini GB, Lobo RA. Eur. Endocrinol. 2009 Oct;161(4):583-9. doi: 10.1530/EJE-09-0398. Epub 2009 Jul 15 (http://www.ncbi.nlm.nih.gov/pubmed/19605540)
  • Neck circumference a good predictor of raised insulin and free androgen index in obese premenopausal women: changes with weight loss. Dixon JB, O'Brien PE. Clin Endocrinol (Oxf). 2002 Dec;57(6):769-78. [7]
  • Crosignani PG, Nicolosi AE (2001). "Polycystic ovarian disease: heritability and heterogeneity". Hum. Reprod. Update 7 (1): 3–7. doi:10.1093/humupd/7.1.3. PMID 11212071.
  • Carmina, E; Koyama, T; Chang, L; Stanczyk, FZ; Lobo, RA (December 1992). "Does ethnicity influence the prevalence of adrenal hyperandrogenism and insulin resistance in polycystic ovary syndrome?". American journal of obstetrics and gynecology 167 (6): 1807–12. PMID 1471702.
  • Azziz R (March 2006). "Diagnosis of Polycystic Ovarian Syndrome: The Rotterdam Criteria Are Premature". Journal of Clinical Endocrinology & Metabolism 91 (3): 781–785. doi:10.1210/jc.2005-2153.PMID 16418211 (http://press.endocrine.org/doi/abs/10.1210/jc.2005-2153)
  • The Rotterdam ESHRE/ASRM-sponsored PCOS consensus workshop group (2004). "Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome (PCOS)". Human Reproduction 19 (1): 41–47. doi:10.1093/humrep/deh098.PMID 14688154. Retrieved 14 November 2011 (http://humrep.oxfordjournals.org/content/19/1/41.long).
  • Carmina E (February 2004). "Diagnosis of polycystic ovary syndrome: from NIH criteria to ESHRE-ASRM guidelines.". Minerva ginecologica 56 (1): 1–6.PMID 14973405 (https://www.ncbi.nlm.nih.gov/pubmed/14973405).
  • Hart R, Hickey M, Franks S (October 2004). "Definitions, prevalence and symptoms of polycystic ovaries and polycystic ovary syndrome". Best Practice & Research Clinical Obstetrics & Gynaecology 18 (5): 671–83.doi:10.1016/j.bpobgyn.2004.05.001. PMID 15380140 (https://www.ncbi.nlm.nih.gov/pubmed/15380140).
  • Legro RS, Kunselman AR, Dodson WC, Dunaif A (1999). "Prevalence and predictors of risk for type 2 diabetes mellitus and impaired glucose tolerance in polycystic ovary syndrome: a prospective, controlled study in 254 affected women". J. Clin. Endocrinol. Metab. 84 (1): 165–9.doi:10.1210/jc.84.1.165. PMID 9920077 (http://press.endocrine.org/doi/full/10.1210/jcem.84.1.5393?view=long&pmid=9920077)
  • Kelly, C. J.; Stenton, S. R.; Lashen, H. (2010). "Insulin-like growth factor binding protein-1 in PCOS: a systematic review and meta-analysis". Human Reproduction Update 17(1): 4–16. doi:10.1093/humupd/dmq027. PMID 20634211. (http://humupd.oxfordjournals.org/content/17/1/4)
  • Gleicher N, Weghofer A, Lee IH, Barad DH (2010). "FMR1 Genotype with Autoimmunity-Associated Polycystic Ovary-Like Phenotype and Decreased Pregnancy Chance". In Mailund, Thomas. PLoS ONE 5 (12): e15303.doi:10.1371/journal.pone.0015303. PMC 3002956.PMID 21179569. (https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3002956/).
  • Veltman-Verhulst SM, Boivin J, Eijkemans MJ, Fauser BJ (2012). "Emotional distress is a common risk in women with polycystic ovary syndrome: a systematic review and meta-analysis of 28 studies". Hum. Reprod. Update 18 (6): 638–51. doi:10.1093/humupd/dms029.PMID 22824735. (http://humupd.oxfordjournals.org/content/18/6/638).
  • Moran, LJ; Ko, H; Misso, M; Marsh, K; Noakes, M; Talbot, M; Frearson, M; Thondan, M; Stepto, N; Teede, HJ (2013 Sep-Oct). "Dietary composition in the treatment of polycystic ovary syndrome: a systematic review to inform evidence-based guidelines.". Human reproduction update19 (5): 432. PMID 23727939. (https://www.ncbi.nlm.nih.gov/pubmed/23727939).
  • Lord JM, Flight IHK, Norman RJ (2003). "Metformin in polycystic ovary syndrome: systematic review and meta-analysis". BMJ 327 (7421): 951–3.doi:10.1136/bmj.327.7421.951. PMC 259161.PMID 14576245. (http://www.bmj.com/content/327/7421/951).
  • Leeman L, Acharya U (August 2009). "The use of metformin in the management of polycystic ovary syndrome and associated anovulatory infertility: the current evidence".J Obstet Gynaecol 29 (6): 467–72.doi:10.1080/01443610902829414. PMID 19697191. (http://informahealthcare.com/doi/abs/10.1080/01443610902829414).
  • Qiao, J.; Feng, H. L. (2010). "Extra- and intra-ovarian factors in polycystic ovary syndrome: impact on oocyte maturation and embryo developmental competence".Human Reproduction Update 17 (1): 17.doi:10.1093/humupd/dmq032. PMC 3001338.PMID 20639519. (https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3001338/).
  • Legro RS, Barnhart HX, Schlaff WD (2007). "Clomiphene, Metformin, or Both for Infertility in the Polycystic Ovary Syndrome". N Engl J Med 356 (6): 551–66. doi:10.1056/NEJMoa063971. PMID 17287476. (http://www.nejm.org/doi/full/10.1056/NEJMoa063971).
  • Galazis, N; Galazi, M; Atiomo, W (April 2011). "D-Chiro-inositol and its significance in polycystic ovary syndrome: a systematic review". Gynecological endocrinology : the official journal of the International Society of Gynecological Endocrinology 27 (4): 256–62.doi:10.3109/09513590.2010.538099. PMID 21142777. (http://informahealthcare.com/doi/abs/10.3109/09513590.2010.538099).
  • Unfer, V; Carlomagno, G; Dante, G; Facchinetti, F (July 2012). "Effects of myo-inositol in women with PCOS: a systematic review of randomized controlled trials".Gynecological endocrinology : the official journal of the International Society of Gynecological Endocrinology 28(7): 509–15. doi:10.3109/09513590.2011.650660.PMID 22296306. (http://informahealthcare.com/doi/abs/10.3109/09513590.2011.650660).
  • Agrawal R, Sharma S, Bekir J, Conway G, Bailey J, Balen AH, Prelevic G. (2004). "Prevalence of polycystic ovaries and polycystic ovary syndrome in lesbian women compared with heterosexual women". J Fertil Steril 82 (5): 1352–1357.doi:10.1016 / j.fertnstert.2004.04.041. PMID 15533359 (http://www.fertstert.org/article/S0015-0282(04)02227-7/abstract)[ligação inativa].

nichd.nih.gov

oup.com

academic.oup.com

oxfordjournals.org

humupd.oxfordjournals.org

  • Androgen excess fetal programming of female reproduction: a developmental aetiology for polycystic ovary syndrome? D.H. Abbott, D.K. Barnett, C.M. Bruns and D.A. Dumesic. Oxford Journals. Human Reproduction Update. July/August 2005. Volume 11, Issue 4. Pp. 357-374 (http://humupd.oxfordjournals.org/content/11/4/357.full).
  • Murri, Mora; Luque-Ramírez, Manual et al. (2013). "Circulating markers of oxidative stress and polycystic ovary syndrome (PCOS): a systematic review and meta-analysis". Hum. Reprod. Update 19 (3): 268-288. doi:10.1093/humupd/dms059. PMID 23303572 (http://humupd.oxfordjournals.org/content/19/3/268)
  • Kelly, C. J.; Stenton, S. R.; Lashen, H. (2010). "Insulin-like growth factor binding protein-1 in PCOS: a systematic review and meta-analysis". Human Reproduction Update 17(1): 4–16. doi:10.1093/humupd/dmq027. PMID 20634211. (http://humupd.oxfordjournals.org/content/17/1/4)
  • Veltman-Verhulst SM, Boivin J, Eijkemans MJ, Fauser BJ (2012). "Emotional distress is a common risk in women with polycystic ovary syndrome: a systematic review and meta-analysis of 28 studies". Hum. Reprod. Update 18 (6): 638–51. doi:10.1093/humupd/dms029.PMID 22824735. (http://humupd.oxfordjournals.org/content/18/6/638).

humrep.oxfordjournals.org

  • Sexual precocity after immigration from developing countries to Belgium: evidence of previous exposure to organochlorine pesticides. M. Krstevska-Konstantinova, C. Charlier, M. Craen, M. Du Caju, C. Heinrichs, C. de Beaufort, G. Plomteux and J.P. Bourguignon. Human Reproduction (2001) 16 (5): 1020-1026. doi: 10.1093/humrep/16.5.1020 (http://humrep.oxfordjournals.org/content/16/5/1020.short)
  • Association between polycystic ovary syndrome and female-to-male transsexuality. Tsuyoshi Baba, Toshiaki Endo, Hiroyuki Honnma, Yoshimitsu Kitajima, Takuhiro Hayashi, Hiroshi Ikeda, Naoya Masumori, Hirofumi Kamiya, Osamu Moriwaka and Tsuyoshi Saito. Human Reproduction Vol.22, No.4 pp. 1011–1016, 2007. Advance Access publication December 13, 2006. doi:10.1093/humrep/del474 (http://humrep.oxfordjournals.org/content/22/4/1011.full.pdf).
  • The Rotterdam ESHRE/ASRM-sponsored PCOS consensus workshop group (2004). "Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome (PCOS)". Human Reproduction 19 (1): 41–47. doi:10.1093/humrep/deh098.PMID 14688154. Retrieved 14 November 2011 (http://humrep.oxfordjournals.org/content/19/1/41.long).

patient.co.uk

pcos.com

pediatricsconsultantlive.com

plosone.org

pubmedcentralcanada.ca

  • Insulin Resistance, Obesity, Inflammation, and Depression in Polycystic Ovary Syndrome: Biobehavioral Mechanisms and Interventions. Kristen Farrell, M.S. and Michael Antoni, Ph.D. Fertil Steril. Author manuscript; available in PMC Oct 1, 2011. Published in final edited form as: Fertil Steril. Oct 2010; 94(5): 1565–1574. Published online May 14, 2010. doi:  10.1016/j.fertnstert.2010.03.081. (http://pubmedcentralcanada.ca/pmcc/articles/PMC2941530/[ligação inativa]).

rcog.org.uk

rollercoaster.ie

sbrh.org.br

  • DIRETRIZES DA SOCIEDADE BRASILEIRA DE REPRODUÇÃO HUMANA. ENDOCRINOLOGIA DA REPRODUÇÃO. Membros da comissão: Sebastião Freitas de Medeiros (relator); Mauri José Piazza; Ricardo Melo Marinho; Alessandro Gomes Schuffener.[4] Arquivado em 19 de dezembro de 2014, no Wayback Machine..

sciencedirect.com

  • The association between men’s ratings of women as desirable long-term mates and individual differences in women’s sexual attitudes and behaviors. Lorne Campbell, Lee Cronk, Jeffry A. Simpson, Alison Milroy, Carol L. Wilson, Bria Dunham. Personality and Individual Differences. Volume 46, Issue 4, March 2009, Pages 509–513 (http://www.sciencedirect.com/science/article/pii/S0191886908004510)

sciencemag.org

  • Epigenetic Transgenerational Actions of Endocrine Disruptors and Male Fertility. Matthew D. Anway, Andrea S. Cupp, Mehmet Uzumcu e and Michael K. Skinner. Published in Science 308:5727 (June 3, 2005), pp. 1466–1469; doi 10.1126/science.1108190 (http://www.sciencemag.org/content/308/5727/1466.abstract)

sciendo.com

springer.com

link.springer.com

verity-pcos.org.uk

web.archive.org

webcitation.org

weebly.com

pcos-polycysticovarysyndrome.weebly.com

womenshealth.gov

worldcat.org